{"id":77814,"date":"2019-04-09T12:25:43","date_gmt":"2019-04-09T08:25:43","guid":{"rendered":""},"modified":"-0001-11-30T00:00:00","modified_gmt":"-0001-11-29T20:00:00","slug":"","status":"publish","type":"post","link":"https:\/\/ucnoqta.az\/?p=77814","title":{"rendered":"Az\u0259rbaycanda bu d\u0259rmanlar <font color=red><b>Qada\u011fan edilib<\/b><\/font>"},"content":{"rendered":"<p><strong>Az\u0259rbaycanda&nbsp;fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin idxal\u0131, p\u0259rak\u0259nd\u0259 v\u0259 topdan sat\u0131\u015f\u0131 qada\u011fan edilib.&nbsp;<\/strong><\/p>\n<p>Ucnoqta.az x\u0259b\u0259r verir ki, bu bar\u0259d\u0259 &quot;Report&quot;a&nbsp;S\u0259hiyy\u0259 Nazirliyind\u0259n m\u0259lumat verilib.&nbsp;<\/p>\n<p>Bildirilib ki,&nbsp;Avropa D\u0259rman Agentliyinin 15&nbsp;fevral tarixli EMA\/114407\/2019 n&ouml;mr\u0259li &ldquo;&Uuml;r\u0259k ritm probleml\u0259ri yaratmas\u0131 il\u0259 ba\u011fl\u0131 potensial risk s\u0259b\u0259bind\u0259n fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin qeydiyyat\u0131n\u0131n dayand\u0131r\u0131lmas\u0131&rdquo; adl\u0131 s\u0259n\u0259d d\u0259rc edilib.<\/p>\n<p>S\u0259n\u0259d\u0259 \u0259sas\u0259n Avropa D\u0259rman Agentliyinin (EMA) farmakon\u0259zar\u0259t &uuml;zr\u0259 riskl\u0259rin qiym\u0259tl\u0259ndirilm\u0259si komit\u0259si (PRAC) u\u015faq v\u0259 yetkinl\u0259rd\u0259 a\u011fciy\u0259r x\u0259st\u0259likl\u0259ri il\u0259 \u0259laq\u0259dar yaranan &ouml;sk&uuml;r\u0259yin aradan qald\u0131r\u0131lmas\u0131 &uuml;&ccedil;&uuml;n istifad\u0259 olunan fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin Avropa Birliyind\u0259 qeydiyyat\u0131n\u0131n dayand\u0131r\u0131lmas\u0131 t\u0259klifini ir\u0259li s&uuml;r&uuml;b. Qeydiyyat\u0131n dayand\u0131r\u0131lmas\u0131 pasiyentl\u0259ri qorumaq &uuml;&ccedil;&uuml;n bir t\u0259dbirdir v\u0259 PRAC QT interval\u0131n\u0131n uzanmas\u0131 v\u0259 &ldquo;torsades de pointes&rdquo; (&uuml;r\u0259k ritm probleml\u0259rin\u0259 yol a&ccedil;a bil\u0259n &uuml;r\u0259yin elektrik f\u0259aliyy\u0259ti anomaliyalar\u0131) riskini n\u0259z\u0259rd\u0259n ke&ccedil;irir. Ke&ccedil;mi\u015fd\u0259 bu d\u0259rmanlar\u0131 q\u0259bul ed\u0259n x\u0259st\u0259l\u0259rd\u0259 &uuml;r\u0259k ritminin probleml\u0259ri diqq\u0259t\u0259 &ccedil;atd\u0131r\u0131l\u0131b.&nbsp;<\/p>\n<p>Fenspirid v\u0259 &uuml;r\u0259k ritm probleml\u0259ri aras\u0131ndak\u0131 potensial \u0259laq\u0259ni ara\u015fd\u0131rmaq &uuml;&ccedil;&uuml;n fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin insanlarda QT interval\u0131n\u0131n uzatma potensial\u0131na malik oldu\u011funu g&ouml;st\u0259r\u0259n heyvan t\u0259dqiqatlar\u0131 apar\u0131l\u0131b. PRAC, m&ouml;vcud olan b&uuml;t&uuml;n s&uuml;butlar\u0131 ara\u015fd\u0131r\u0131r v\u0259 AB-d\u0259 fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259ri bar\u0259d\u0259 t&ouml;vsiy\u0259l\u0259r verir. Qiym\u0259tl\u0259ndirm\u0259 ba\u015fa &ccedil;atd\u0131qdan sonra, EMA m\u0259lumat verm\u0259yi, pasiyent v\u0259 tibb i\u015f&ccedil;il\u0259rin\u0259 yenil\u0259nmi\u015f r\u0259hb\u0259rlik t\u0259qdim etm\u0259yi planla\u015fd\u0131r\u0131r: &quot;Yuxar\u0131da qeyd edil\u0259nl\u0259ri n\u0259z\u0259r\u0259 alaraq, S\u0259hiyy\u0259 Nazirliyi Farmakoloji v\u0259 Farmakopeya Ekspert \u015euras\u0131 t\u0259r\u0259find\u0259n fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin t\u0259hl&uuml;k\u0259sizliyi v\u0259 risk-fayda nisb\u0259ti ara\u015fd\u0131r\u0131l\u0131r.<\/p>\n<p>Ara\u015fd\u0131rmalar\u0131n davam etdiyi m&uuml;dd\u0259td\u0259 \u0259halinin sa\u011flaml\u0131\u011f\u0131n\u0131n qorunmas\u0131 v\u0259 pasiyentl\u0259rin potensial riskd\u0259n qorunmas\u0131 m\u0259qs\u0259di il\u0259 fenspirid t\u0259rkibli a\u015fa\u011f\u0131dak\u0131 d\u0259rman vasit\u0259l\u0259rinin b&uuml;t&uuml;n seriyalar\u0131 geri &ccedil;a\u011f\u0131r\u0131l\u0131b&quot;.<\/p>\n<p>S\u0259hiyy\u0259 Nazirliyi pasiyentl\u0259rin diqq\u0259tin\u0259 &ccedil;atd\u0131r\u0131r ki, t\u0259hl&uuml;k\u0259sizlik m\u0259lumatlar\u0131 g&ouml;st\u0259rir ki, fenspirid t\u0259rkibli &ouml;sk&uuml;r\u0259k \u0259leyhin\u0259 d\u0259rmanlar q\u0259fil ciddi &uuml;r\u0259k ritm probleml\u0259rin\u0259 s\u0259b\u0259b ola bil\u0259r: &quot;Pasiyentl\u0259r\u0259 ara\u015fd\u0131rmalar\u0131n davam etdiyi m&uuml;dd\u0259td\u0259 fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin istifad\u0259sini dayand\u0131rmaq t&ouml;vsiy\u0259 edilir.&nbsp;Fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rini istifad\u0259 ed\u0259n pasiyentl\u0259r &uuml;r\u0259k ritm probl\u0259rin\u0259 m\u0259ruz qala bil\u0259rl\u0259r.&nbsp;<\/p>\n<p>\u018fg\u0259r &ouml;sk&uuml;r\u0259k \u0259leyhin\u0259 fenspirid t\u0259rkibli d\u0259rman vasit\u0259si q\u0259bul edirsinizs\u0259, alternativ m&uuml;alic\u0259l\u0259r haqq\u0131nda m\u0259sl\u0259h\u0259t almaq &uuml;&ccedil;&uuml;n h\u0259kim v\u0259 ya \u0259cza&ccedil;\u0131ya m&uuml;raci\u0259t edin.&nbsp;\u018fg\u0259r istifad\u0259 etdiyiniz d\u0259rmanla ba\u011fl\u0131 h\u0259r hans\u0131 narahatl\u0131q varsa, onlar\u0131 h\u0259kim v\u0259 ya \u0259cza&ccedil;\u0131 il\u0259 m&uuml;zakir\u0259 edin&quot;.<\/p>\n<p>Tibb i\u015f&ccedil;il\u0259ri is\u0259 ara\u015fd\u0131rmalar\u0131n davam etdiyi m&uuml;dd\u0259td\u0259, tibb i\u015f&ccedil;il\u0259ri pasiyentl\u0259r\u0259 fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin istifad\u0259sinin dayand\u0131r\u0131lmas\u0131n\u0131 m\u0259sl\u0259h\u0259t g&ouml;rm\u0259lidirl\u0259r.&nbsp;Fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin istifad\u0259sinin m&uuml;v\u0259qq\u0259ti dayand\u0131r\u0131lmas\u0131 son apar\u0131lan klinikaya q\u0259d\u0259r t\u0259dqiqatlara (hERG kanal birl\u0259\u015fm\u0259si v\u0259 in vitro heyvan modell\u0259ri &uuml;z\u0259rind\u0259 t\u0259dqiqatlar) \u0259saslan\u0131r v\u0259 fenspiridin insanlarda QT interval\u0131n\u0131n uzanmas\u0131 potensial\u0131na malik oldu\u011funu g&ouml;st\u0259rir.<\/p>\n<p>Bu m\u0259lumatlar, fenspirid v\u0259 QT interval\u0131n\u0131n uzanmas\u0131 \/ torsades de pointes aras\u0131ndak\u0131 ehtimal olunan \u015f&uuml;bh\u0259li \u0259laq\u0259nin olmas\u0131n\u0131 t\u0259sdiql\u0259yir.&nbsp;Fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin simptomatik m&uuml;alic\u0259 &uuml;&ccedil;&uuml;n istifad\u0259 olundu\u011funu v\u0259 QT interval\u0131n\u0131n uzamas\u0131n\u0131n ciddiliyi n\u0259z\u0259r\u0259 al\u0131nmaqla, bu t\u0259rkibli d\u0259rmanlar\u0131n t\u0259cili olaraq S\u0259hiyy\u0259 Nazirliyi Farmakoloji v\u0259 Farmakopeya Ekspert \u015euras\u0131n\u0131n yekun q\u0259rar\u0131n\u0131n n\u0259tic\u0259l\u0259rin\u0259 q\u0259d\u0259r t\u0259xir\u0259 sal\u0131n\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Az\u0259rbaycanda&nbsp;fenspirid t\u0259rkibli d\u0259rman vasit\u0259l\u0259rinin idxal\u0131, p\u0259rak\u0259nd\u0259 v\u0259 topdan sat\u0131\u015f\u0131 qada\u011fan edilib.&nbsp; Ucnoqta.az x\u0259b\u0259r verir ki, bu bar\u0259d\u0259 &quot;Report&quot;a&nbsp;S\u0259hiyy\u0259 Nazirliyind\u0259n m\u0259lumat verilib.&nbsp; Bildirilib ki,&nbsp;Avropa D\u0259rman Agentliyinin 15&nbsp;fevral tarixli EMA\/114407\/2019 n&ouml;mr\u0259li &ldquo;&Uuml;r\u0259k&hellip;<\/p>\n","protected":false},"author":1,"featured_media":251278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-77814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/77814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=77814"}],"version-history":[{"count":0,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/posts\/77814\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=\/wp\/v2\/media\/251278"}],"wp:attachment":[{"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=77814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=77814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ucnoqta.az\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=77814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}